Acta Neuropathologica

, Volume 84, Issue 1, pp 100–104

Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins

  • T. Yamada
  • P. L. McGeer
  • E. G. McGeer
Short Original Communications

Summary

The substantia nigra (SN) in 11 Parkinson's disease (PD) patients and 5 neurologically normal controls was examined immunohistochemically using antibodies to various proteins of the complement system. In PD, but not in control SN, intra-and extraneuronal Lewy bodies and dendritic spheroid bodies were stained with anti-human C3d, C4d, C7 and C9 antibodies, but not with antibodies to C1q, fraction Bb of factor B or properdin. Axonal spheroid bodies in the nigrostriatal tract were not stained by any of the complement antibodies. However, complement-activated oligodendroglia were revealed by anti-C3d and anti-C4d antibodies in the PD substantia nigral area. These data indicate that some pathological structures in PD activate the classical complement pathway.

Key words

Parkinson's disease Complement Lewy bodies Oligodendrocytes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bancher C, Lassmann H, Budka H, et al (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81–93Google Scholar
  2. 2.
    Forno LS (1990) Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. In: Stern G (ed) Parkinson's disease. The Johns Hopkins University Press, Baltimore, pp 185–238Google Scholar
  3. 3.
    Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–663Google Scholar
  4. 4.
    Gibb WRG (1987) The epidemiology of Lewy bodies. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease. Macmillan Healthcare Information, New Jersey, pp 1–13Google Scholar
  5. 5.
    Goldman JE, Yen SH (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082–1084Google Scholar
  6. 6.
    Leigh PN, Probst A, Dale GE, et al (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 79:61–72Google Scholar
  7. 7.
    Love S, Saitoh T, Quijada S, Cole GM, et al (1989) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 147:393–405Google Scholar
  8. 8.
    Lowe J, McDermott H, Landon M, et al (1990) Ubiquitin carboxyl-teminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153–160Google Scholar
  9. 9.
    McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574–576Google Scholar
  10. 10.
    McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107:341–346Google Scholar
  11. 11.
    Morgan BP (1989) Complement membrane attack on nucleated cells: resistence, recovery and non-lethal effects. Biochem J 264:1–14Google Scholar
  12. 12.
    Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96Google Scholar
  13. 13.
    Papolla MA (1986) Lewy bodies of Parkinson's disease. Arch Pathol Lab Med 110:1160–1163Google Scholar
  14. 14.
    Yamada T, Akiyama H, McGeer PL (1990) Complementactivated oligodendroglia: a new pathological entity identified by immunostaining with antibodies to human complement proteins C3d and C4d. Neurosci Lett 112:161–166Google Scholar
  15. 15.
    Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D 28K. Brain Res 526:303–307Google Scholar
  16. 16.
    Yamada T, Akiyama H, McGeer PL (1991) Two types of spheroid bodies in the nigral neurons in Parkinson's disease. Can J Neurol Sci 18:287–294Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • T. Yamada
    • 1
    • 2
  • P. L. McGeer
    • 1
    • 2
  • E. G. McGeer
    • 1
    • 2
  1. 1.Kinsmen Laboratory of Neurological Research, Department of PsychiatryUniversity of British Columbia VancouverCanada
  2. 2.Neurodegenerative Diseases CentreUniversity of British Columbia VancouverCanada
  3. 3.University of B.C.VancouverCanada

Personalised recommendations